Articles in section Research & Development
<< Opinion & Analysis | 452 articles | Royalties >> |
<< Previous | Pages 1 ..1 2 3 4 5 6 .. 46 | Next >> |
-
Gilead Signs US$1.7 B Deal with MacroGenics for Bispecific Antibodies
-
Bayer’s Vividion Signs US$930 M Cancer Collaboration with Tavros Therapeutics
-
Abpro Signs US$1.75 B Collaboration Deal with Celltrion
-
AbbVie Collaborates with Sosei Heptares to Develop Small Molecules for Neurological Conditions
-
Roche Bolsters Pipeline with Poseida and Kiniksa Deals
-
Merck & Co. Pays US$35 M Upfront for Kelun-Biotech’s ADC Oncology Drug
-
Merck & Co. Collaborates with Orion to Develop and Commercialise ODM-208 for US$290 M
-
Generian and Mitobridge Form Alliance to Develop Novel Small Molecules for Undruggable Targets
-
Sanofi Signs US$2.54 B Collaboration Deal with Skyhawk Therapeutics for RNA-splicing Modulators
-
Novartis Collaborates with Precision Bio in Gene Editing Pact